NCT04285034View on ClinicalTrials.gov

Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever

CompletedOBSERVATIONAL

Enrollment

158

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

July 15, 2021

Study Completion Date

July 15, 2021

Conditions

Lassa Fever

Trial Locations (1)

PMB 1053

Owo Federal Medical Centre, Owo

All Listed Sponsors

lead

University of Oxford

OTHER

NCT04285034 - Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever | Biotech Hunter | Biotech Hunter